Four Nipah cases, two deaths and a first outbreak in Palakkad, WHO reports

The World Health Organization has published an account of four laboratory-confirmed Nipah virus infections in the Indian state of Kerala, including two deaths, reported by the state government through a series of press releases between 17 May and 12 July 2025 [s1]. Two of the cases came from Malappuram district and two from Palakkad, which had never previously recorded a Nipah case [s1].

The detail that matters most in the WHO account is what connects the four patients: nothing. The sources of infection remain under investigation, and none of the cases appear to be linked to each other — a pattern WHO reads as independent spillover events from the natural animal reservoir rather than a transmission chain among people [s1]. A significant presence of fruit bats, the known reservoir for the virus, has been observed in the affected areas [s1].

What was reported, and when

The first patient was an adult woman from Malappuram whose symptoms began on 25 April [s1]. She was admitted to a local hospital with fever, cough and respiratory distress, moved to intensive care on 2 May as acute encephalitis syndrome developed, tested positive at Calicut Medical College on 6 May, and had that result confirmed by the National Institute of Virology in Pune on 8 May [s1].

The second, also an adult woman from Malappuram, developed symptoms on 23 June and died on 1 July after visiting several healthcare facilities before clinical suspicion of Nipah prompted testing [s1]. The third, an adult woman from Palakkad with symptom onset on 25 June, was in critical condition on ventilator support at the time of the WHO report — the first confirmed case in that district [s1]. The fourth, an adult man from Palakkad, developed symptoms on 6 July, was admitted to a private hospital on 10 July, transferred on 11 July, and died on 12 July with infection confirmed [s1].

WHO does not name the patients, and neither does this account.

Why the case count understates the response

By 17 July, contact tracing had identified 723 individuals as contacts of confirmed cases across several districts — 394 in Palakkad, 212 in Malappuram, 114 in Kozhikode, two in Ernakulam and one in Thrissur [s1]. Twenty-six special teams were deployed to trace contacts, monitor symptoms and inform the public, and health authorities issued alerts to hospitals across six districts instructing them to report suspected cases [s1]. Kerala health authorities also released route maps for the movements of the three cases reported in July, so that people who might have crossed paths with them could come forward [s1].

That ratio — four confirmed cases, hundreds of traced contacts, dozens of deployed teams — is the shape of Nipah response everywhere it occurs. There is no licensed vaccine and no approved treatment, so the entire public health toolkit is detection, isolation and supportive care [s1][s2].

The recurring-spillover pattern

Kerala has now reported nine Nipah outbreaks since 2018 [s1]. WHO lists the sequence: 23 confirmed and probable cases with a case-fatality rate of 91% in 2018; a single case who survived in 2019; one case with a fatal outcome in 2021; six cases including two deaths in 2023; two cases in 2024 with both dying; and the four in 2025 [s1].

A 2025 review in Nature Microbiology describes the broader picture. Nipah is a zoonotic paramyxovirus that infects Pteropus fruit bat species across South and Southeast Asia, and since its discovery in Malaysia in the late 1990s it has caused human outbreaks in Singapore, Bangladesh, India and the Philippines [s2]. The review puts the mean case-fatality rate at 70% and states plainly that the spillover pathway for the 2023 Kerala outbreak remains speculative [s2]. WHO's own figure is a range: 40% to 100% across outbreaks in Bangladesh, India, Malaysia and Singapore, depending on local capacity for early detection and clinical management [s1]. Both figures are in the sources; neither should be treated as a single fixed number.

Indian researchers reporting on Kerala's 2024 outbreaks noted a clinical division worth watching. Outbreaks in which acute encephalitis syndrome predominated — 2019, 2021 and 2024 — showed no human-to-human transmission, whereas outbreaks in which acute respiratory distress syndrome predominated — 2001, 2007, 2018 and 2023 — did [s3]. That is an observed association across a small number of events, not an established mechanism, and it should not be read as a rule.

What WHO says about risk

WHO assesses the overall risk to the broader national and regional population as low, and the risk of international spread as low, noting no evidence of international human-to-human transmission in this event [s1]. Recent case numbers in Kerala are consistent with trends observed in previous years and are therefore "not entirely unexpected," in WHO's phrasing, though they continue to highlight a localised risk [s1].

Two caveats sit inside that assessment. Nosocomial transmission was confirmed during the 2023 outbreak, and infection prevention, control and waste management practices have since been strengthened and audited [s1]. And studies have found fruit bats testing positive for Nipah antibodies in several other Indian states, which means the virus could emerge outside Kerala [s1].

What to watch

The immediate open question is the source of infection for the 2025 cases, which was unconfirmed at the time of the WHO report [s1]. Beyond that, the Nature Microbiology review argues that the field needs coordinated laboratory and field work under a One Health strategy — treating human, animal and environmental surveillance as one system — to prevent future epidemics rather than only respond to them [s2]. Kerala has built the detection capacity to find these cases quickly. The harder problem is knowing when and where the next spillover will happen.

Sources

• Nipah Virus Infection - India — World Health Organization, Disease Outbreak News, 2025-08-06
• A One Health approach to understanding and managing Nipah virus outbreaks — Nature Microbiology, 2025-05-28
• Encephalitis-predominant Nipah virus outbreaks in Kerala, India during 2024 — Journal of Infection and Public Health, 2025-04-16